NEW YORK, Jan. 23, 2009

Stem Cell Study Gets Federal Go-Ahead

Starting This Summer, U.S. Company Will Undertake Spinal Cord Treatment Research

  •  (AP)

  • Timeline Stem Cell Debate

    The scientific advance sets off an ethical debate that rages on.

  • Interactive Stem Cell Research

    Follow the debate, and learn how and why the cells are harvested.

(AP)  A U.S. biotech company says it plans to start this summer the world's first study of a treatment based on human embryonic stem cells - a long-awaited project aimed at spinal cord injury.

The company gained federal permission this week to inject eight to 10 patients with cells derived from embryonic cells, said Dr. Thomas Okarma, president and CEO of Geron Corp. of Menlo Park, Calif.

The patients will be paraplegics, who can use their arms but can't walk. They will receive a single injection within two weeks of their injury.

The study is aimed at testing the safety of the procedure, but doctors will also look for signs of improvement like return of sensation or movement in the legs, Okarma said.

Whatever its outcome, the study will mark a new chapter in the contentious history of embryonic stem cell research in the United States - a field where debate spilled out of the laboratory long ago and into national politics.

While some overseas doctors claim to use human embryonic stem cells in their clinics, stem cell experts said they knew of no previous human studies that use such cells.

"It's a milestone and it's a breakthrough for the field" because Geron passed the safety hurdles for getting federal clearance to launch the study, said Ed Baetge, chief scientific officer of Novocell Inc. His company hopes to begin a similar human study for treating diabetes in a few years.

In addition, said spinal cord injury researcher Dr. Wise Young of Rutgers University, "a lot of hope of the spinal cord injury community is riding on this trial."

Embryonic stem cells can develop into any cell of the body, and scientists have long hoped to harness them for creating replacement tissues to treat a variety of diseases. But research has been controversial because embryos must be destroyed to obtain them.

President Barack Obama has promised to relax the Bush administration's restrictions on federal financing for such research. But Mr. Obama's ascent to the White House had nothing to do with the U.S. Food and Drug Administration's granting permission for the new study, Okarma said in a telephone interview Thursday.

In fact, the company says, the project involves stem cells that were eligible for federal funding under Bush, although no federal money was used to develop the experimental treatment or to pay for the human study.

Other human cells, called adult stem cells, have been tested before in people to treat heart problems, for example.

In the Geron study, the injections will be made in the spine at the site of damage. The work will be done in four to seven medical centers around the country, Okarma said.

Animal studies suggest that once injected, the cells will mature and repair what is essentially a lack of insulation around damaged nerves, and also pump out substances that nerves need to function and grow.

Apart from assessing safety, investigators will hope to see some signs of improvement in the patient, Okarma said. The idea is "not to make somebody ... get up and dance the next day," he said, but rather to provide some level of ability that can be improved by physical therapy.

Each patient will receive a low dose of anti-rejection drugs for about two months, because after that time the medications shouldn't be needed, Okarma said. The study will follow each patient for at least a year.

Okarma said he can't estimate how much such a therapy would cost if it proves effective, but that "this is not going to be a $500,000 price tag. It will be remarkably affordable ... in the context of the value it provides."

Evan Snyder, a stem cell researcher at the Burnham Institute for Medical Research in La Jolla, Calif., said scientists in the field will focus chiefly on the study's results about safety.

"The one hope that everybody has is that nothing bad happens," he said.

Geron Corp. has spent at least $100 million on human embryonic stem cell research. Founded in 1992, it does not have any therapies on the market.

However, the company is considered the world's leading embryonic stem cell developer thanks to its claims on several key stem cell technologies. Geron helped finance researchers at the University of Wisconsin who first isolated human embryonic stem cells in 1998. The company has retained exclusive rights on several of those cell types.

© MMIX The Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.
Share:
  • Share
  • Yahoo! Buzz
  • Mixx
Add a Comment See all 67 Comments
by JamesB621 January 26, 2009 2:28 AM EST
When it''s a woman they call it abortion, when it''s a chicken they call it an omlette!
Reply to this comment
by JamesB621 January 26, 2009 2:21 AM EST
When it''s a woman they call it abortion, when it''s a chicken they call it an omlette!
Reply to this comment
by JamesB621 January 26, 2009 2:16 AM EST
You evangelicals are a real piece of work, "life begins at conception".
well if that''s true then think of this, when an egg is fertilized it takes several days for it to implant in the uterus, and not every fertilized egg makes it that far, most of them are rinsed out of the body every 28 days or so, never implanting and resulting in pregnancy, so what you''re telling us is that every sexually active woman who has had more than one menstrual cycle is a serial killer!
These people are just another example of ignorance waving the bible trying to depriving those of us with permanent disease and disability (I''m a paraplegic) of a chance to become whole again.
Reply to this comment
by brainteaser2 January 25, 2009 8:55 PM EST
To healthspeak: Your comment on resveratrol is full of inaccuracies all of the "miraculous effect" you describe above are theoretical none have been demonstrated in humans. In the lone test done on humans the dose was actually 3-5 grams (not 250 mg.) So as usual "if it sounds to good to be true it probably is" especially at the ridiculous price it is sold at.
Reply to this comment
by kirstinharr January 25, 2009 7:55 PM EST
Obama wasn''t my choice but I''m so thankful to see him overturn the Bush policies on Stem Cell Research. I would gladly give them every one of my remaining eggs to further research. Diseases could be reversed and we are 8 years behind the power curve. I don''t think Obama has the experience required for the job he''s undertaken but if he continues to reverse those Bush mistakes (Iraq, Gitmo, Stem Cells, Patriot Act) then, he will get my vote in 2012.
Reply to this comment
by healthspeak January 25, 2009 5:58 AM EST
Resveratrol can help you to lead a long and healthy life and prevent disease so say many doctors, stem cell therapy not perfected yet.. Red wine alone does not supply enough resveratrol to achieve the full range of benefits because one glass of red wine has only about 1mg of resveratrol and you need about 250mg/day. You need to take
high potency resveratrol supplements to achieve the results documented
in scientific studies.Resveratrol Supplements can also help you control
your weight naturally by increasing energy, reducing cravings, and limiting
your appetite.According to Wikipedia, Consumer Lab, an independent dietary
supplement and over the counter products evaluation organization,
published a report on 13 November 2007 on the popular resveratrol
supplements. The organization reported that there exists a wide range
in quality, dose, and price among the 13 resveratrol products
evaluated. The actual amount of resveratrol contained in the
different brands range from 2.2mg for Revatrol, which claimed to have
400mg of "Red Wine Grape Complex", to 500mg for Biotivia.com Transmax,
which is consistent with the amount claimed on the product''s label.
Prices per 100mg of resveratrol ranged from less than $.30 for
products made by Biotivia.com, jarrow, and country life, to a high of
$45.27 for the Revatrol brand.

Reply to this comment
by exusmcsgt January 24, 2009 10:21 AM EST
Can you imagine what a miracle it would be if this treatment could repair spinal cord damage and return function to someone who is paralyzed. Even if they got limited function back it would be amazing. Exciting stuff.

Posted by kansas1946 at 09:10 PM : Jan 23, 2009

And you''d see the Jesus freaks who opposed the research lining up to reap the benefits if it''s successful....
Reply to this comment
by smirk22-2009 January 24, 2009 4:48 AM EST
It''s about time this center-left nation puts leaders in place that do the things that most people support.
Reply to this comment
by kansas1946 January 24, 2009 12:10 AM EST
Can you imagine what a miracle it would be if this treatment could repair spinal cord damage and return function to someone who is paralyzed. Even if they got limited function back it would be amazing. Exciting stuff.
Reply to this comment
by strangeworld January 23, 2009 10:39 PM EST
"If it is okay to use an embryo of any age to do scientific research, then what is the difference between a one day old embryo and a teenager?"

One''s trying to leave the womb, the other is trying to enter it?
Reply to this comment
See all 67 Comments

Exclusive Webshow

Author Thomas Friedman on Obama's Afghanistan plan and the war on terror. Watch Now

Latest News
News in Pictures
Scroll Left Scroll Right
Connect with CBS News

Stay connected with the CBS News using your favorite social networks and online news applications: